USD 140.16
(-3.49%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 296.55 Million | 367.06 Million | 383.69 Million | 115.05 Million | 270.55 Million | 242.89 Million |
Net Income | 258.5 Million | 332.15 Million | 288.95 Million | 75.38 Million | 222.87 Million | 216.35 Million |
Depreciation & Amortization | 75.73 Million | 63.91 Million | 50.49 Million | 48.45 Million | 36.12 Million | 33.92 Million |
Deferred income taxes | -1.33 Million | -19.64 Million | -1 Million | -44.82 Million | 9.81 Million | -3.51 Million |
Stock-based compensation | 46.8 Million | 42.97 Million | 35.73 Million | 9.69 Million | 17.61 Million | 15.98 Million |
Change in working capital | 6.12 Million | -5.07 Million | 23.24 Million | 11.48 Million | -21.82 Million | -2.03 Million |
Other non-cash items | -89.28 Million | -47.25 Million | -13.72 Million | 14.86 Million | 5.95 Million | -17.83 Million |
Investing Cash Flow | -265.62 Million | -442.43 Million | -78.92 Million | -29.46 Million | -251.16 Million | -321.25 Million |
Investments in PPE | -118.29 Million | -93.58 Million | -77.86 Million | -39.95 Million | -64.04 Million | -49.47 Million |
Acquisitions | -38.06 Million | -553.57 Million | 12.77 Million | 1.98 Million | -29.67 Million | -240.92 Million |
Investment purchases | -116.61 Million | -4.18 Million | -1.7 Million | -2.56 Million | -3.17 Million | -2.89 Million |
Sales/Maturities of investments | 1.6 Million | 1.9 Million | 2.6 Million | 2.47 Million | 2.21 Million | 2.82 Million |
Other Investing Activities | 5.73 Million | 207.01 Million | -14.73 Million | 8.58 Million | -156.49 Million | -30.78 Million |
Financing Cash Flow | -45.93 Million | -394.15 Million | -27.72 Million | 115.39 Million | -12.49 Million | -129.41 Million |
Debt repayment | -366.94 Million | -272.54 Million | -11.05 Million | -506.68 Million | -329.2 Million | -29.03 Million |
Dividends payments | -56.45 Million | -52.54 Million | -25.04 Million | -25.27 Million | -48.08 Million | -48.71 Million |
Common Stock Repurchased | -362.77 Million | -434.76 Million | -13.36 Million | -55.45 Million | -50.63 Million | -148.67 Million |
Common Stock Issuance | 6.34 Million | 3.8 Million | 11.05 Million | 707.42 Million | 443.78 Million | 41.36 Million |
Other Financing Activities | 733.89 Million | 361.89 Million | 10.68 Million | -4.62 Million | -28.34 Million | 38.94 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 6.12 Million | -5.07 Million | 23.24 Million | 11.48 Million | -21.82 Million | -2.03 Million |
Cash at beginning of period | 41.56 Million | 511.6 Million | 234.77 Million | 33.76 Million | 26.64 Million | 235.33 Million |
Cash at end of period | 26.75 Million | 41.56 Million | 511.6 Million | 234.77 Million | 33.76 Million | 26.64 Million |
Capital Expenditure | -118.29 Million | -93.58 Million | -77.86 Million | -39.95 Million | -64.04 Million | -49.47 Million |
Effect of forex changes on cash | 197 Thousand | -520 Thousand | -224 Thousand | 33 Thousand | 230 Thousand | -921 Thousand |
Net cash flow / Change in cash | -14.81 Million | -470.03 Million | 276.82 Million | 201.01 Million | 7.12 Million | -208.69 Million |
Free Cash Flow | 178.26 Million | 273.47 Million | 305.82 Million | 75.09 Million | 206.51 Million | 193.42 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 106.31 Million | 86.69 Million | 30.85 Million | 28.95 Million | 258.5 Million | 92.02 Million |
Depreciation & Amortization | 10.86 Million | 10.82 Million | 10.93 Million | 18.72 Million | 75.73 Million | 18.59 Million |
Deferred income taxes | -18.39 Million | -1.95 Million | -736 Thousand | 2.97 Million | -1.33 Million | -6.47 Million |
Stock-based compensation | 13.19 Million | 8.65 Million | 10.59 Million | 12.13 Million | 46.8 Million | 10.98 Million |
Change in working capital | 18 Million | 15.49 Million | -33.5 Million | 15.27 Million | 6.12 Million | 27.67 Million |
Other non-cash items | -7.03 Million | 20.49 Million | 16.06 Million | -28.7 Million | -89.28 Million | -21.35 Million |
Investing Cash Flow | -1.33 Million | -19.29 Million | -42.73 Million | -162.36 Million | -265.62 Million | -44.11 Million |
Investments in PPE | 75.24 Million | -41.02 Million | -34.21 Million | -34.99 Million | -118.29 Million | -36.22 Million |
Acquisitions | 3.63 Million | 5.68 Million | -9.31 Million | -14.35 Million | -38.06 Million | -9.24 Million |
Investment purchases | -48.72 Million | -437 Thousand | -1.04 Million | -112.93 Million | -116.61 Million | -472 Thousand |
Sales/Maturities of investments | 75.92 Million | 32.29 Million | 2.11 Million | 346 Thousand | 1.6 Million | 164 Thousand |
Other Investing Activities | -107.41 Million | -10.12 Million | -9.59 Million | -419 Thousand | 5.73 Million | 1.66 Million |
Financing Cash Flow | -123.6 Million | -75.03 Million | 56.47 Million | 103.07 Million | -45.93 Million | -76.88 Million |
Debt repayment | -298.74 Million | -172.24 Million | -126.5 Million | -182.13 Million | -366.94 Million | -6.5 Million |
Dividends payments | -13.63 Million | -14.12 Million | -14.72 Million | -14.38 Million | -56.45 Million | -14.53 Million |
Common Stock Repurchased | -56.25 Million | -233.25 Million | -59.45 Million | -58.37 Million | -362.77 Million | -69.94 Million |
Common Stock Issuance | -4.26 Million | 101 Thousand | 4.16 Million | -5.5 Million | 6.34 Million | 1.1 Million |
Other Financing Activities | 249.28 Million | -2.65 Million | 130.66 Million | 363.46 Million | 733.89 Million | 13 Million |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | 5.5 Million | - | 14.02 Million | -6.7 Million | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | 18 Million | 15.49 Million | -33.5 Million | 6.7 Million | 6.12 Million | 27.67 Million |
Cash at beginning of period | 60.4 Million | 42.11 Million | 26.75 Million | 36.43 Million | 41.56 Million | 36.16 Million |
Cash at end of period | 58.56 Million | 60.4 Million | 42.11 Million | 26.75 Million | 26.75 Million | 36.43 Million |
Capital Expenditure | 75.24 Million | -41.02 Million | -34.21 Million | -34.99 Million | -118.29 Million | -36.22 Million |
Effect of forex changes on cash | 146 Thousand | 777 Thousand | -121 Thousand | 247 Thousand | 197 Thousand | -190 Thousand |
Net cash flow / Change in cash | -1.84 Million | 18.29 Million | 15.35 Million | -9.67 Million | -14.81 Million | 265 Thousand |
Free Cash Flow | 198.18 Million | 70.82 Million | -32.47 Million | 14.36 Million | 178.26 Million | 85.22 Million |
PRECWIRE
CMS-PB
2531
MLSUM
BIO
TGP